Two different perspectives in the management of pT3 and/or margin-positive prostate cancer after radical prostatectomy

BJU Int. 2006 Oct;98(4):773-6. doi: 10.1111/j.1464-410X.2006.06423.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Combined Modality Therapy
  • Disease-Free Survival
  • Humans
  • Male
  • Middle Aged
  • Neoplasm, Residual
  • Prostate-Specific Antigen / metabolism
  • Prostatectomy / methods*
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / therapy*
  • Radiotherapy, Adjuvant*
  • Treatment Outcome

Substances

  • Prostate-Specific Antigen